Lymphocyte Biology
BioLympho
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublications in collaboration with researchers from GlaxoSmithKline (United Kingdom) (1)
2021
-
Cost-effectiveness analysis of anti–IL-5 therapies of severe eosinophilic asthma in Spain
Journal of Medical Economics, Vol. 24, Núm. 1, pp. 874-882